Introduction
The HMGA2 (syn.: HMGIC) protein belongs to the high-mobility group (HMG) family of nonhistone chromatin proteins that act as architectural transcription factors (for a review, see Bustin and Reeves, 1996) . HMGA2, whose gene maps to 12q14-15, consists of three DNA-binding domains designated as AT-hooks, enabling its binding to the minor groove of AT-rich DNA, and an acidic C-tail responsible for proteinprotein interactions (Solomon et al., 1986; Chau et al., 1995) . The interaction of HMGA2 with DNA leads to changes in DNA-conformation modulating the environment for the assembly and function of transcriptional complexes, thus influencing the expression of a huge variety of genes.
Whereas HMGA2 is expressed at very high levels during embryonic development, it is almost undetectable in differentiated cells (Chiappetta et al., 1996; Rogalla et al., 1996) . The embryonic expression of HMGA2 has been studied in detail in mice (HirningFolz et al., 1998) . At an early embryonic stage, HMGA2 mRNA is found in all tissues, whereas the pattern of expression is restricted particularly to mesenchymal derivatives, some epithelial cell layers, and parts of the central nervous system in the second half of embryonic development. Furthermore, the role of HMGA2 in adipogenesis has emerged based on the observations that HMGA2 knockout mice show a pygmy phenotype with a characteristic reduction of body weight, mainly affecting fat tissue , and that transgenic mice carrying a truncated HMGA2 gene lacking the acidic C-tail develop a giant phenotype and predominantly abdominal and pelvic lipomatosis (Battista et al., 1999) . Moreover, knockout mice lacking HMGA2 resisted diet-induced obesity (Anand and Chada, 2000) . A reactivation of HMGA correlates with the formation of arteriosclerotic plaques and aortic restenosis (Chin et al., 1999) as well as the development of malignant (Tamimi et al., 1996) and benign tumors (e.g. uterine leiomyomas) Schoenmakers et al., 1995; Kazmierczak et al., 1996; Scala et al., 2000) .
So far, a restricted number of investigations have aimed at the analysis of the HMGA2 promoter in humans and mice (Ayoubi et al., 1999; Chau et al., 1999; Rustighi et al., 1999 Rustighi et al., , 2002 , showing multiple transcription initiation sites as observed in many TATA-less promoters. Herein, we performed luciferase reporter assays in both HMGA2 positive and negative tumor cell lines to identify novel sequences influencing HMGA2 promoter activity.
Based on previously published data (Ashar et al., 1996; Ayoubi et al., 1999; Chau et al., 1999; Rustighi et al., 1999) and sequence alignments (e.g., gb-accessionno.: NM_003483; Z31595; U28749), two regions of main transcription initiation (RTI) could be determined ranging from nucleotide (nt) À161 to À201 (proximal RTI (pRTI)) and nt À790 to À893 (distal RTI (dRTI)) relative to the ATG translational start codon of human HMGA2. Based on these analyses, several overlapping promoter fragments spanning the region nt À1 to À2240 were cloned upstream of a luciferase reporter gene and were analyzed for promoter activity in three different human cell lines (HeLa, MCF7, and L14tsv40). Of these clones, construct P5 (region À1418 to À1) spanning the distal and proximal region of transcription initiation (pRTI and dRTI) showed the highest promoter activity in all cell lines tested and was set at 100% relative promoter activity for comparative analyses (Figure 1a) . Clones P2 and P7 spanning pRTI and dRTI, respectively, showed promoter activity in all three cell lines tested, thus revealing the presence of at least two independent functional gene promoters that are capable of inducing HMGA2 transcription on their own. These data are consistent with the sequence alignments described above showing that HMGA2 gene transcription is initiated at two different regions (pRTI and dRTI), and previous experiments in the hepatoma cell line PLC/PRF/5 indicating that HMGA2 gene transcription might be initiated from two independent transcription initiation sites (Chau et al., 1999) .
Furthermore, we performed luciferase experiments with deletion mutants (clones P7-P10) of the distal promoter ( Figure 1a ). Although only minor changes were measured by these experiments, the significant differences between clones P7-P10 led to the identification of negative regulatory elements (region À1194 to À1717), elements that are regulated in a cell-typespecific manner (region À1718 to À2097), and a positive regulatory element 2098-2240 bp upstream of the HMGA2 ATG start codon. Furthermore, these experiments showed that the distal promoter element (dRTI, clone P7) showed a remarkably high promoter activity in cell line L14tsv40 relative to HeLa and MCF7, suggesting that the variations in promoter activity Human HMGA2 promoter L Borrmann et al underline cell-type-specific activation mechanisms because of different transcription factor settings in the analyzed cell lines.
As the most interesting result, luciferase experiments with promoter construct P3 containing a TCTCT(TC) 36 -repeat at its 5 0 end almost doubled the promoter activity in comparison to the construct P2 lacking the TCTCT(TC) 36 -repeat and 40 bp upstream of it in a highly significant manner for HeLa (Po0.01) and L14tsv40 cells (Po0.01). In contrast, only slight activity difference between the two constructs was detected in MCF7 cells. To finally prove that the TC-repeat coregulates the promoter activity, we generated two clones of fragment P5 containing one (TC 1 ) and 22 (TC 22 ) TC-dinucleotides, respectively. Luciferase experiments performed within cell line L14tsv40 showed a significant (Po0.05) reduction in activity of about 45% of clone P5-TC 1 relative to clone P5 containing a TC 36 -repeat (Figure 1b) . These data are consistent with the results obtained for clone P3 in relation to P2 within L14tsv40 (Figure 1a) . Furthermore, although clone P5-TC 22 had only 84% promoter activity compared with clone P5-TC 36 , this clone showed a significant (P ¼ 0.05) 1.5-fold higher activity when compared to clone P5-TC 1 . These data indicate that the TC-repeat contributes to the transcriptional activation of HMGA2. Moreover, by performing sequence analysis of this TC-repeat from 20 unrelated, apparently normal individuals, we could identify a length polymorphism ranging between 22 and 36 dinucleotide copies. These findings are consistent with previously described studies revealing dinucleotide repeat variations between 18 and 37 copies (Ishwad et al., 1997) . In contrast to previous publications (Patel et al., 1994) and sequence databases (L41044; U28750) showing a TCTCT(TC) n TG(TC) n -repeat, our sequencing approach of several individuals did not verify the intermediate TG dinucleotide, and accordingly the repeat motif was described as TCTCT(TC) n .
Interestingly, we determined promoter activity in both HMGA2 mRNA positive (MCF7, L14tsv40) and negative (HeLa) tumor cell lines consistently with previously published data (Ayoubi et al., 1999) , also showing an active promoter in HMGA2 mRNA positive and negative cell lines. These results suggest that beyond a constitutive active promoter, there have to be negative regulatory elements that were not present in the 5 0 flanking regions analyzed so far controlling the HMGA2 expression. One of those regulatory elements could be located within the 3 0 UTR of HMGA2 because it was shown that HMGA2 expression depends on the length of the 3 0 UTR (Borrmann et al., 2001) , suggesting expressional control at the post-transcriptional level.
To find out more about regulatory mechanisms of the HMGA2 gene in this report, a series of functional promoter assays with different fragments of its promoter region were performed. Besides the confirmation of at least two independent promoter regions explaining the main cluster of transcription initiation, the existence of novel regulatory elements was identified and the polymorphic dinucleotide repeat (TCTCT(TC) n ) 502 bp upstream of the ATG was found to be a strong positive regulator of the HMGA2 promoter. Furthermore, this is the first paper reporting on TCTCT(TC) n as the only sequence motif in all analyzed cases, in contrast to previous published sequences showing an internal TG dinucleotide element. The effect of this repeat element on promoter activity could probably be explained by the formation of non-B-form-DNA-conformations that are involved in transcription. For example, as described in the literature, (dT-dC) n repeats are able to adopt a hinged DNA structure (H-DNA), which is composed of triple-stranded and single-stranded regions Dahlberg, 1988, 1989) . Moreover, those polypyrimidine repetitive sequences capable of forming H-DNA are known to occur with high frequency in eucaryotic genomes, particularly around promoter regions, and have been shown to be involved in chromatin structure formation (Lu et al., 1993; Espina´s et al., 1996) and transcriptional activation (Michel et al., 1992; Firulli et al., 1994; Kim et al., 1998) . In addition to the results presented herein, an evolutionary conserved polypyrimidine/polypurine tract (nt À235 to À197; L41044) that is also a positive regulatory element on the human (Chau et al., 1999) and murine (Rustighi et al., 1999) HMGA2 promoter was recently described to adopt non-B-DNA-conformations, such as triple-helical H-DNA in vitro (Rustighi et al., 2002) .
As the most interesting result, we were able to show not only that the polymorphic dinucleotide repeat (TCTCT(TC) n ) is a strongly positive regulator of the HMGA2 promoter but also that different repeat lengths contribute to clear differences in HMGA2 promoter activity. These results offer strong evidence that the length of the polymorphic TCTCT(TC) n element is a crucial factor for HMGA2 transcriptional activity, thus implicating an individual or ethnical predisposition for certain disorders such as arteriosclerosis, restenosis, and obesity in which HMGA2 dysregulation is involved. Furthermore, these data may give a first explanation for the much higher incidence of uterine leiomyomas in African Americans compared to Caucasians (Meilahn et al., 1989) , as there are clear ethnical differences in allelic frequency of different TCTCT(TC) n -repeat lengths between African Americans and Caucasians (Ishwad et al., 1997) .
Nevertheless, further experiments need to be done to give a more detailed view on the mechanisms of transcriptional activation exerted by the TCTCT(TC) nrepeat. Promoter clones of different TCTCT(TC) nrepeat lengths are under construction and will be analyzed.
Material and methods

PCR amplification of HMGA2 promoter elements
For amplification of HMGA2 promoter fragments, HindIII-primer 5 0 -CCCAAGCTTCTGCCCGGGCTG-GAAGTTTTC-3 0 was used in combination with BglIIprimer 5 0 -GGAAGATCTAGGACAACTGCCCAGG-GGTGAC-3 0 (clone P7, nt 1749-2172, L41044), and 5 0 -TCGCAGGGTGGGGGGAAGAGGA-3 0 , respectively. PCR reactions were performed with pfu polymerase in a Mastercycler gradient (Eppendorf, Hamburg, Germany) using the following protocol: 5 min 941C, (1 min 941C, 1 min 60-641C, 1 min 721C) Â 35, 10 min 721C. As template, a cosmid spanning the HMGA2 promoter region was used. Clone P5 was used as a template for the amplification of P5-TC 1 fragments. For P5-TC 22 , genomic DNA of a person carrying a TC 22 allele was used as a template for PCR.
Plasmid constructions, cell culture, and promoter assay
The amplified promoter fragments were cloned into the HindIII-BglII or KpnI-BglII sites of pGL3-Basic vector (Promega, Madison, USA). P5-TC 1 PCR fragments were cut with KpnI and BglII, blunt end ligated, and afterwards cloned into the KpnI-BglII site of pGL3-Basic vector. Plasmid DNA was isolated using the Plasmid Isolation Kit (Qiagen, Hilden, Germany) following the instructions of the manufacturer. Clones were verified by sequencing.
Cell culture of cell lines HeLa (cervix carcinoma), MCF7 (breast cancer), and L14tsv40 (lipoma, having a t(3; 12)(q27; q14) translocation involving HMGA2) as well as promoter assay experiments were performed as described elsewhere, with some minor modifications (Borrmann et al., 2001) . Briefly, luciferase activities were measured after 48 h, and the experiments for each construct were performed in duplicate and repeated three times. For statistical analysis, a one-sample t-test was performed, with Pr0.05 for significant and Pr0.01 for highly significant differences.
Detection of polymorphic CT-repeat
DNA of 20 unrelated, normal individuals was isolated by the salt extraction method. A PCR spanning the CT repeat was performed with primer 5 0 -ATCCTCCTTTGCTTTCCGACTGC-3 0 and 5 0 -AC-CTCATCTCCCGAAAGGTGCTG-3 0 using Hot Star Taq (Qiagen, Hilden, Germany) in a Mastercycler gradient (Eppendorf, Hamburg, Germany) by the following protocol: 15 min 951C, (1 min 941C, 1 min 661C, 1 min 721C) Â 35, 10 min 721C. For analysis of polymorphic variants, PCRs were separated on 4% small DNA agarose gel (Biozym, Hessisch Oldendorf, Germany), fragments were isolated from gel using QIAEX II (Qiagen, Hilden, Germany), cloned into pGEM T-easy (Promega, Madison, USA), and analyzed by sequencing with a special protocol for repetitive sequences (Seqlab, Go¨ttingen, Germany).
